Articles by James Calloway
Barclays Shares Slide 5% Despite Q2 Profit Beat as Cost Concerns Mount
Barclays shares dropped over 5% on Tuesday, even as Q2 pretax profit and income exceeded expectations. Rising costs and a portfolio sale gain tempered investor enthusiasm.
Nokia Shares Edge Up Amidst €2.8B AI Orders and Insider Buying
Nokia shares inched up 1% to €8.01 following €2.8B in AI orders, insider buying, and mixed Q2 results. Revenue conversion and cash flow remain key investor concerns.
American Airlines Stock Rebounds on Oil Slide, Fuel Costs Still a Drag
American Airlines stock recovered as oil prices fell, but fuel costs remain a key concern. A 10-cent per gallon increase adds $460M in annual expenses.
Celestica Soars 8% After Raising Full-Year Guidance, Q4 Revenue Implied at $6.35B
Celestica shares surged 8% after raising its 2026 outlook, with Q4 revenue implied at $6.35 billion and adjusted EPS at $3.62, driven by robust AI and cloud demand.
Intel Holds Steady in Premarket as AI Server Demand Boosts Earnings Outlook
Intel shares slipped 0.7% in premarket, outperforming peers, as AI server demand drove a 59% surge in data center revenue and Q3 guidance beat consensus.
Navitas Q3 Outlook: 71% Distributor Concentration Raises Risk Flag
Navitas Semiconductor (NVTS) forecasts Q3 revenue midpoint of $13.5M, up 28% sequentially, but 71% of Q2 sales came from one distributor, raising concentration concerns.
Amkor Technology Beats Q2 Targets but Soft Q3 Outlook Weighs on Shares
Amkor Technology (AMKR) exceeded Q2 expectations but issued a cautious Q3 revenue forecast, causing shares to fall 6.5%.
Archer Aviation Holds $390M Gain After Q2 Earnings Preview
Archer Aviation closed Monday with an estimated $390 million gain, up 3.8% to $4.95, ahead of Q2 earnings on August 10.
Universal Health Services Slumps on Profit Warning; Buybacks Lift EPS
Universal Health Services shares dropped 5% in after-hours trading after the hospital operator lowered its 2026 profit outlook, citing Medicaid reimbursement uncertainty. Q2 EPS beat estimates but growth was mostly from share repurchases.
OPKO Stock Jumps 8% After Q2 Beat, Nicoya Deal Lifts Outlook
OPKO Health shares jumped 8% after hours as Q2 revenue beat by $32.35 million, largely from Nicoya preferred shares. The company also raised its 2026 revenue outlook.
Opendoor Stock Steady at $3.85 as Q2 Earnings Focus Shifts to Margins
Opendoor shares ended Monday at $3.85, gaining 0.4% after a sharp weekly drop. Q2 earnings due Aug. 4 will spotlight margin improvements and adjusted EBITDA progress.